LEGN | Legend Biotech Corporation
Category: Consumer goods
Quick infos Headquarters: Somerset, Ewing Township, New Jersey, United States Trade prices Volume: Market Cap: 6.52B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: January 31, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast November 29, 2022 - / -0.3673- / 32.55MSeptember 2, 2022 -0.35 / -0.310215.2M / 33.62MBeat! June 1, 2022 -0.13 / -0.358340.83M / 25MBeat! March 18, 2022 -0.3 / -0.341839M / 14.27MBeat! November 16, 2021 -0.43 / -0.415616.88M / 7.83MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jul 25, 2022 50.48 49.43 50.98
49.43
489.84K 1.77% Jul 22, 2022 49.60 49.50 50.04
48.98
463.73K 0.20% Jul 21, 2022 49.50 48.09 50.40
47.62
1.37M 2.89% Jul 20, 2022 48.11 51.35 52.76
47.46
1.21M -7.27% Jul 19, 2022 51.88 50.60 52.44
49.95
553.93K 3.64% Jul 18, 2022 50.06 53.80 54.28
49.84
758.93K -6.34% Jul 15, 2022 53.45 53.76 54.34
52.38
628.65K -0.39% Jul 14, 2022 53.66 54.77 55.13
53.30
852.56K -2.52% Jul 13, 2022 55.05 54.15 56.80
54.09
891.64K -0.56% Jul 12, 2022 55.36 54.58 56.15
53.61
511.31K 1.43% view more
LEGN
News
CORRECTED-UPDATE 2-FDA approves cancer therapy by J&J, partner Legend Biotech finance.yahoo.com Jan 25, 2023 9:14 pm
Legend Biotech Announces FDA Clinical Hold of its Phase 1 Clinical Trial for LB1901 finance.yahoo.com Jan 25, 2023 8:30 am
Legend Biotech Announces FDA Clearance of the IND for LB1901, an Investigational Autologous Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma finance.yahoo.com Jan 25, 2023 8:00 am UPDATE 2-European drug regulator clears J&J, Legend's CAR-T therapy finance.yahoo.com Jan 25, 2023 7:52 am
FDA Approves JNJ-Legend Biotech Partnered Blood Cancer Therapy finance.yahoo.com Jan 25, 2023 7:49 am
Legend Biotech Corp - ADR to Host Earnings Call finance.yahoo.com Jan 25, 2023 6:15 am Legend Biotech gets Nasdaq non-compliance notice seekingalpha.com Jan 9, 2023 11:59 pm J&J, Legend Biotech's Carvykti for multiple myeloma gets review in China seekingalpha.com Jan 3, 2023 5:24 pm
Legend Biotech to Participate in the 41st Annual JP Morgan Healthcare Conference finance.yahoo.com Jan 3, 2023 4:01 pm
Is Legend Biotech Corporation (LEGN) A Good Investment? finance.yahoo.com Dec 26, 2022 8:37 pm Legend Biotech initiated at outperform at Cowen on strength of Carvykti seekingalpha.com Nov 2, 2022 1:26 am Legend Biotech climbs as analysts probe JNJ Q3 results to estimate Carvykti sales seekingalpha.com Oct 19, 2022 3:52 am
Why Legend Biotech's Shares Jumped 14.2% On Tuesday finance.yahoo.com Oct 18, 2022 5:14 pm Catalyst watch: Eyes on automakers, Hasbro, Costco and Box seekingalpha.com Oct 1, 2022 3:00 am Legend Biotech Stock Joins Elite Club Of Stocks With RS Ratings Over 90 investors.com Sep 1, 2022 2:07 pm
Should You Buy Legend Biotech (LEGN) Ahead of Earnings? finance.yahoo.com Aug 16, 2022 10:13 am
Legend Biotech Corporation Sponsored ADR (LEGN) Soars 10.9%: Is Further Upside Left in the Stock? finance.yahoo.com Jul 28, 2022 8:30 am
Legend Biotech Corporation Announces Pricing of Public Offering finance.yahoo.com Jul 26, 2022 8:00 pm
Legend Biotech Corporation Announces Proposed Public Offering finance.yahoo.com Jul 25, 2022 4:01 pm
Health Check: How Prudently Does Legend Biotech (NASDAQ:LEGN) Use Debt? finance.yahoo.com Jul 20, 2022 10:11 am This company doesn't provide a dividend.
Talk about Legend Biotech Corporation below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.legendbiotech.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 90 HOLD 10 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!